Sponsors & Exhibitors

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.

For questions on the corporate boilerplate, please contact COMMUNICATIONS_CORPORATE@lilly.com.

Novo Nordisk is a global healthcare company with more than 100 years of innovation and leadership in diabetes care. We are offering one of the broadest portfolios of diabetes products in the industry and are a supplier of nearly half of the world’s insulin with more than 40 million people using our products. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, hemophilia and growth disorders.

Headquartered in Denmark, Novo Nordisk employs more than 69,000 people in 80 countries and markets its products in more than 170 countries.

Our key contribution is to discover and develop innovative biological medicines and make them accessible to patients throughout the world. We aim to lead in all disease areas in which we are active.

For more information, you can visit novonordisk.com.

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow.

At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love. Founded in Chicago 135 years ago, Abbott is currently serving people in more than 160 countries with leading medical devices, diagnostics, nutrition products and branded generic medicines. Our 115,000 colleagues are helping millions of people to live better and healthier.

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products.

We are focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology has revolutionized how people monitor glucose and provides physicians with more data to make better informed treatment decisions.

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

At Bayer, our vision is to make better life a reality for billions of people around the world through every day healthcare. Through our broad geographic footprint and portfolio of leading and trusted brands, people can get well, be well and stay well by taking charge of their everyday health, and the health of those they love. We touch billions of lives, helping provide them with safe, convenient and effective daily health solutions to treat minor illness and improve their lives.

Follow us on social media: Linkedin.

Insulet Corporation (NASDAQ: PODD), is an innovative medical device company dedicated to simplifying life for people with diabetes through its Omnipod® product platform. The Omnipod DASH® Insulin Management System provides an alternative to traditional insulin delivery methods. With its simple, tubeless and waterproof* design, the single use Pod provides up to three days of continuous insulin delivery. For more information, please visit: www.insulet.com and www.omnipod.com.

*The Pod has a waterproof IP28 rating for up to 7.6 metres for 60 minutes.

Founded to serve health, Servier is a global pharmaceutical group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 22,000 employees of the Group are committed to this shared vocation, a source of inspiration every day.

As a world leader in cardiology, Servier’s ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology.

Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine.

To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.

In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.

Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €5.3 billion in 2023.

More information on the new Group website: servier.com

Follow us on social media: LinkedIn, Facebook, Twitter, Instagram

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

We are Merck, a leading global science and technology company headquartered in Germany.

We are curious explorers, courageous pioneers, and ingenuous inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life science, Healthcare, and Electronics.

Together, we dream big and are passionate about caring for our mix of people, customers, patients, and the planet.

We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue reaching for the future worth living.

As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Recordati is a growing renowned international pharmaceutical group.

We are an international pharmaceutical group dedicated to the research, development, manufacturing, and marketing of innovative medicines to achieve our purpose: improve people’s health and quality of life.

We offer high-quality accessible products in various therapeutic areas through our Specialty & Primary Care business, and our Rare Diseases business provides treatments for serious unmet medical needs.

We are growing continuously thanks to the quality of our products and our implementation of an internationalization policy based on a focused strategy of selective acquisitions and licence agreements.

RECORDATI IN A NUTSHELL

• HQ in Milan, Italy has been listed on the Italian stock exchange since 1984.
• Produces and promotes a wide range of innovative products in around 150 countries.
• Exceed 4,450 employees.
• Portfolio includes products for both primary and specialty care and treatments for rare diseases.
• Two pharmaceutical chemicals plants (Italy and Ireland).
• Seven pharmaceutical manufacturing plants:
  • Italy
  • France
  • Spain
  • Switzerland
  • Tunisia
  • Turkey
  • Czech Republic
• One packaging and distribution plant handling drugs for rare diseases (France).
• Recordati Rare Diseases division focuses on three key franchises:
  • Metabolic
  • Endocrinology
  • Oncology

VIVUS is a biopharmaceutical company committed to advancing innovative clinical therapies. With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with expertise and insights to advance innovative new therapies.

As an international leader with over 12 years of clinical experience in treating overweight and obesity as a chronic disease with Qsymia® (phentermine and topiramate extended release) CIV, a non-injection weight management brand for adults & pediatric patient patients aged 12 -17 years, VIVUS remains committed to providing treatment options for patients globally.

Through its partnership with PharmaAccess, VIVUS can streamline operations in the GCC region, effectively reaching healthcare providers and patients, particularly with the availability of Qsymia® in the UAE. PharmaAccess provides VIVUS with fully integrated solutions, managing essential functions in Marketing, Sales and Distribution, Regulatory, Medical, and Pharmacovigilance.

PharmaAccess aims to help partners optimize pharmaceutical operations in the GCC while addressing customers' medical needs through its comprehensive solutions. By offering a centralized, competitive platform and continuously expanding its services and pipeline, PharmaAccess delivers dynamic, up-to-date strategies to ensure long-term success and sustained growth for its partners.

Empowering People to Take Control of Health
Dexcom, Inc. provides innovative continuous glucose monitoring (CGM) systems to people with Type 1 and Type 2 diabetes. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.

We are Modern Pharmaceutical Company LLC, more simply known as MPC. We are the UAE’s leading distributor and healthcare service provider within the pharma and healthcare industry. With a successful track record spanning over 50 years, we offer a comprehensive portfolio of products and solutions serving hospitals, medical centers, institutions, retailers, wholesalers and directly delivering to more than 2,500 pharmacies (>95% market coverage). We provide the strongest back-end support & infrastructure systems, machinery, logistics, through the best people in the market. MPC is the trusted partner of some of the world’s most influential healthcare-focused multi-national companies and we represent these global leaders within pharmaceuticals, medical equipment, health, and consumer care. We partner with our customers every day to ensure we bring much-needed medicine and medical equipment to support their patient’s needs.

For over decades we have been a major partner in the advancement of healthcare in the UAE motivated by a single objective: Excellence in our products and services to satisfy the needs of our principles and patients.

Healthcare is one of the key pillars of the Albatha Group which was founded in the early 1950s by Sheikh Mohammed Sultan Al Qassimi, whose vision and entrepreneurship have made us one of the largest conglomerates in the UAE.

MPC is committed to be the outstanding integrated healthcare services provider to our customers & principals based on trust, availability & innovation.

WOur vision is to create a world without limits for people with diabetes and related conditions.

For more than 40 years LifeScan has advanced glucose management and diabetes care with pioneering technologies and new products defined by simplicity, accuracy and trust.

From OneTouch® brand blood glucose meters, test strips, and lancets to an integrated digital health platform and hospital point-of-care systems, LifeScan is committed to offering patient-centric products and clinically-proven solutions.

Through partnerships with industry leaders, we will usher in the next wave of personalized health and wellness experiences that engage people with diabetes and related conditions to live their best lives.

We accomplish our vision by living our shared values of Care, Create, Connect and Compete. These values guide our actions and are the cornerstone of all that we do.

EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological product.

With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.

Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 70 countries worldwide.

Established in 1977 by Dr. Jumaa Belhoul, Pharma World LLC is a 100% Emirati-owned Limited Liability Company operating under the Belhoul Group, a leading healthcare conglomerate in the UAE. Alongside Gulf & World Traders, a prominent player in the medical equipment sector, Pharma World is a key entity within the group, contributing to its strong presence in the healthcare industry.

Pharma World specializes in the importation, registration, distribution, marketing, and sale of a wide range of healthcare products. These include pharmaceutical products, medical devices, disinfectants, skincare items, cosmeceuticals, food supplements, and dietary nutrition. The company is committed to delivering high-quality healthcare solutions to improve patient outcomes and quality of life.

Mission

Pharma World’s mission is to provide safe, effective, and affordable healthcare solutions by licensing, distributing, and promoting essential medicines. The company aligns with global efforts to ensure access to vital medications and enhance public health. It prioritizes product safety, regulatory compliance, and adherence to ethical standards, ensuring trust and reliability in the pharmaceutical industry.

Vision

The company’s vision focuses on expanding its reach in developing markets by leveraging its internal marketing and sales expertise. Pharma World aims to advance medical knowledge, improve public health, and deliver innovative, safe, and effective treatments to patients. Ethical considerations and regulatory compliance remain central to its operations, guided by core values that emphasize integrity, responsibility, and patient-centric care.

Through its commitment to excellence, Pharma World continues to play a pivotal role in the UAE’s healthcare sector, contributing to the well-being of communities and the advancement of medical science.

Pharmalink Drug Store is a leading pharmaceutical distributor in the UAE with more than 30 years of experience, committed to providing high-quality healthcare solutions and a diverse range of pharmaceutical products. Established to meet the growing needs of the healthcare sector, Pharmalink focuses on enhancing patient care by ensuring access to essential medications and innovative therapies.

The company prides itself on its extensive portfolio, which includes prescription medications, over-the-counter products, and specialized therapies. Collaborating with reputable pharmaceutical companies allows Pharmalink to offer products that meet the highest standards of quality and efficacy. Its partnership with Abiogen Pharma since 2019 has further strengthened its product offerings, enhancing its ability to serve patients effectively.

Gulf Med Medicines is providing sales, marketing and distribution services for healthcare business partners through a very ambitious and highly competitive team.

Gulf Med Medicines has branches in the middle east, providing regional business at regional standards.

Gulf Med Medicines has more than 150 employees across its subsidiaries in the UAE , Saudi Arabia, Qatar , Oman , Kuwait, Egypt , Libya and Iraq.

Gulf Med Medicines is a dynamic organization with high capability of building new lines through its dedicated team and powerful market access.